Indivumed GmbH was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy. As a physician-led, integrated global oncology company our experts leverage the world’s premier multi-omics oncology database and highest quality biobank to develop a true picture of cancer. Our three divisions operate holistically with one another for the generation, characterization, and analysis of biologic samples from human cancer patients. Indivumed is headquartered in Hamburg, Germany, with a US-based subsidiary and a global clinical network.